Skip to content

Clinical trials

Completed Thrombocytopenia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Status: Completed Country / region: France Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20053
20062
20081
20093
20111
20132
20143
20151
20171
20192
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
Centre Hospitalier Universitaire de Saint Etienne2
Eisai Inc.2
Novartis Pharmaceuticals2
Centre Henri Becquerel1
Centre Hospitalier Annecy Genevois1
Centre Leon Berard1
Groupe Francophone des Myelodysplasies1
Institut National de la Santé Et de la Recherche Médicale, France1
Nantes University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia22
Purpura, Thrombocytopenic, Idiopathic5
Purpura3
Hematologic Neoplasms2
Hepatitis C2
Myelodysplastic Syndromes2
Glioblastoma1
Hemorrhage1
Hepatitis C, Chronic1
Hodgkin Disease1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.